Stratos Wealth Partners, Ltd. Eli Lilly & CO Transaction History

Stratos Wealth Partners, Ltd.

  • $6.79 Billion
  • Q3 2024

A detailed history of Stratos Wealth Partners, Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Stratos Wealth Partners, Ltd. holds 35,622 shares of LLY stock, worth $28.3 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
35,622
Previous 35,207 1.18%
Holding current value
$28.3 Million
Previous $31.9 Million 0.99%
% of portfolio
0.47%
Previous 0.52%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024
BUY
$772.14 - $960.02 $320,438 - $398,408
415 Added 1.18%
35,622 $31.6 Million
Q2 2024

Jul 24, 2024
SELL
$724.87 - $909.04 $373,308 - $468,155
-515 Reduced 1.44%
35,207 $31.9 Million
Q1 2024

Apr 16, 2024
BUY
$592.2 - $792.28 $795,324 - $1.06 Million
1,343 Added 3.91%
35,722 $27.8 Million
Q4 2023

Jan 24, 2024
BUY
$525.19 - $619.13 $1.02 Million - $1.21 Million
1,948 Added 6.01%
34,379 $20 Million
Q3 2023

Oct 24, 2023
BUY
$434.7 - $599.3 $1.51 Million - $2.08 Million
3,472 Added 11.99%
32,431 $17.4 Million
Q2 2023

Jul 18, 2023
BUY
$350.74 - $468.98 $1.23 Million - $1.64 Million
3,506 Added 13.77%
28,959 $13.6 Million
Q1 2023

Apr 27, 2023
BUY
$310.63 - $364.82 $491,416 - $577,145
1,582 Added 6.63%
25,453 $8.74 Million
Q4 2022

Jan 19, 2023
SELL
$321.55 - $374.67 $438,915 - $511,424
-1,365 Reduced 5.41%
23,871 $0
Q3 2022

Oct 24, 2022
SELL
$296.48 - $337.87 $190,340 - $216,912
-642 Reduced 2.48%
25,236 $8.16 Million
Q2 2022

Jul 22, 2022
BUY
$278.73 - $327.27 $182,010 - $213,707
653 Added 2.59%
25,878 $8.39 Million
Q1 2022

Apr 26, 2022
SELL
$234.69 - $291.66 $5,163 - $6,416
-22 Reduced 0.09%
25,225 $7.22 Million
Q4 2021

Jan 14, 2022
BUY
$224.85 - $279.04 $637,899 - $791,636
2,837 Added 12.66%
25,247 $6.97 Million
Q3 2021

Oct 19, 2021
SELL
$221.6 - $272.71 $20,608 - $25,362
-93 Reduced 0.41%
22,410 $5.18 Million
Q2 2021

Jul 19, 2021
BUY
$180.55 - $233.54 $1.45 Million - $1.88 Million
8,039 Added 55.58%
22,503 $5.17 Million
Q1 2021

Apr 27, 2021
BUY
$164.32 - $212.72 $72,465 - $93,809
441 Added 3.14%
14,464 $2.7 Million
Q4 2020

Jan 29, 2021
BUY
$130.46 - $172.63 $110,760 - $146,562
849 Added 6.44%
14,023 $2.37 Million
Q3 2020

Oct 29, 2020
SELL
$146.22 - $169.13 $24,272 - $28,075
-166 Reduced 1.24%
13,174 $1.95 Million
Q2 2020

Jul 28, 2020
BUY
$136.42 - $164.18 $196,444 - $236,419
1,440 Added 12.1%
13,340 $2.19 Million
Q1 2020

May 04, 2020
BUY
$119.05 - $147.35 $74,049 - $91,651
622 Added 5.52%
11,900 $1.65 Million
Q4 2019

Jan 29, 2020
BUY
$106.92 - $132.43 $2,993 - $3,708
28 Added 0.25%
11,278 $1.48 Million
Q3 2019

Nov 12, 2019
BUY
$106.79 - $116.16 $1.19 Million - $1.3 Million
11,164 Added 12981.4%
11,250 $1.26 Million
Q3 2019

Nov 12, 2019
SELL
$106.79 - $116.16 $1.31 Million - $1.43 Million
-12,283 Reduced 99.3%
86 $1.59 Million
Q2 2019

Aug 06, 2019
SELL
$110.79 - $129.32 $213,270 - $248,941
-1,925 Reduced 13.47%
12,369 $1.37 Million
Q1 2019

May 07, 2019
BUY
$111.31 - $131.02 $394,371 - $464,203
3,543 Added 32.96%
14,294 $1.86 Million
Q4 2018

Feb 08, 2019
SELL
$105.9 - $118.64 $26,898 - $30,134
-254 Reduced 2.31%
10,751 $1.24 Million
Q3 2018

Nov 02, 2018
SELL
$85.86 - $107.31 $130,335 - $162,896
-1,518 Reduced 12.12%
11,005 $1.18 Million
Q2 2018

Aug 13, 2018
SELL
$75.7 - $86.88 $32,248 - $37,010
-426 Reduced 3.29%
12,523 $1.07 Million
Q1 2018

May 10, 2018
BUY
$74.21 - $87.6 $108,049 - $127,545
1,456 Added 12.67%
12,949 $1 Million
Q4 2017

Feb 09, 2018
BUY
$81.94 - $87.89 $18,026 - $19,335
220 Added 1.95%
11,493 $971,000
Q3 2017

Nov 07, 2017
BUY
$77.07 - $85.54 $868,810 - $964,292
11,273
11,273 $964,000

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Stratos Wealth Partners, Ltd. Portfolio

Follow Stratos Wealth Partners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email